✦ LIBER ✦

Tridimensional assessment of adductor spasmodic dysphonia pre- and post-treatment with Botulinum toxin

✍ Scribed by P. H. Dejonckere; K. J. Neumann; M. B. J. Moerman; J. P. Martens; A. Giordano; C. Manfredi

Book ID: 113040026
Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 522 KB
Volume: 269
Category: Article
ISSN: 0302-9530
DOI: 10.1007/s00405-011-1890-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined-modality treatment of adductor

Combined-modality treatment of adductor spasmodic dysphonia with botulinum toxin and voice therapy

✍ Thomas Murry; Gayle E. Woodson 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 531 KB

Sporadic failure of botulinum toxin trea

Sporadic failure of botulinum toxin treatment in usually responsive patients with adductor spasmodic dysphonia

✍ G. Galardi; R. Guerriero; S. Amadio; L. Leocani; R. Teggi; G. Melloni; G. Comi 📂 Article 📅 2001 🏛 Springer Milan 🌐 English ⚖ 48 KB

Double-blind controlled study of botulin

Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia

✍ Daniel D. Truong; Michael Rontal; Michael Rolnick; Arnold E. Aronson; Kathy Mist 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 418 KB

Assessing the Effectiveness of Botulinum

Assessing the Effectiveness of Botulinum Toxin Injections for Adductor Spasmodic Dysphonia: Clinician and Patient Perception

✍ Maia N. Braden; Michael M. Johns III; Adam M. Klein; John M. Delgaudio; Marina G 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 121 KB

Unilateral Versus Bilateral Injections o

Unilateral Versus Bilateral Injections of Botulinum Toxin in Patients with Adductor Spasmodic Dysphonia

✍ Steven Bielamowicz; Sheila V Stager; Andrea Badillo; Alexis Godlewski 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Safety and efficacy of botulinum toxin t

Safety and efficacy of botulinum toxin type B (Myobloc) in adductor spasmodic dysphonia

✍ Charles H. Adler; Stephen F. Bansberg; Kari Krein-Jones; Joseph G. Hentz 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

## Abstract This single‐site, open‐label, dose‐finding study evaluated the safety and efficacy of botulinum toxin type B (BoNT‐B; Myobloc) for the treatment of adductor spasmodic dysphonia (AdSD) in 13 patients. Three patients received a total of 50 U (25 U per vocal fold); the same three subsequen